First Patient to Evaluate Pharmacokinetics and Pharmacodynamics of Anafilm™ (Epinephrine) Sublingual Film in Acquisitive Therapeutics Doses Phase 3 Pivotal Clinical Study

First Patient to Evaluate Pharmacokinetics and Pharmacodynamics of Anafilm™ (Epinephrine) Sublingual Film in Acquisitive Therapeutics Doses Phase 3 Pivotal Clinical Study

Acquisitive Therapeutics, Inc. WARREN, NJ, Dec. 05, 2023 (GLOBE NEWSWIRE) — Acquisitive Therapeutics, Inc. Technologies (NASDAQ: AQST) (the Company or Acquis), a pharmaceutical company developing medicines to make meaningful improvements in patients’ lives through innovative science and delivery, dosed the first patient in its initial Phase 3 pivotal pharmacokinetic (PK) clinical study of Anafilm (epinephrine) … Read more